Literature DB >> 32624464

High bleeding risk and clinical outcomes in East Asian patients undergoing percutaneous coronary intervention: the PENDULUM registry.

Masato Nakamura1, Kazushige Kadota, Koichi Nakao, Yoshihisa Nakagawa, Junya Shite, Hiroyoshi Yokoi, Ken Kozuma, Kengo Tanabe, Raisuke Iijima, Atsushi Harada, Takeshi Kuroda, Yoshitaka Murakami.   

Abstract

AIMS: We aimed to evaluate the validity of the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria for East Asian patients undergoing contemporary percutaneous coronary intervention (PCI) from the PENDULUM registry. METHODS AND
RESULTS: This post hoc analysis included 6,267 Japanese patients undergoing PCI between December 2015 and June 2017 enrolled in PENDULUM. The primary endpoint was the incidence of major bleeding at 12 months post index PCI. In total, 3,185 (50.8%) and 3,082 (49.2%) patients were stratified to the ARC-HBR and non-ARC-HBR groups, respectively, and almost all patients had overlapping criteria. Incidence of major bleeding was 4.2% versus 1.4% in the ARC-HBR group versus the non-ARC-HBR group (hazard ratio 3.00 [95% confidence interval: 2.11-4.27]; p<0.001). As the number of overlapping ARC-HBR criteria increased, the incidence of major bleeding also increased. In contrast, the incidence of major bleeding was 4.2% for one major criterion, 2.1% for two minor criteria. Multivariate analysis suggested that severe CKD, anticoagulant use, acute coronary syndrome, low body weight and heart failure were independent predictors of major bleeding.
CONCLUSIONS: Half of the Japanese patients who underwent PCI in the PENDULUM registry met the ARC-HBR criteria, and many patients had overlapping criteria. ARC-HBR criteria are applicable to Japanese patients undergoing contemporary PCI.

Entities:  

Year:  2021        PMID: 32624464     DOI: 10.4244/EIJ-D-20-00345

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


  6 in total

1.  Academic Research Consortium High Bleeding Risk Criteria associated with 2-year bleeding events and mortality after transcatheter aortic valve replacement discharge: a Japanese Multicentre Prospective OCEAN-TAVI Registry Study.

Authors:  Kazuki Mizutani; Gaku Nakazawa; Tomohiro Yamaguchi; Mana Ogawa; Tsukasa Okai; Fumiaki Yashima; Toru Naganuma; Futoshi Yamanaka; Norio Tada; Kensuke Takagi; Masahiro Yamawaki; Hiroshi Ueno; Minoru Tabata; Shinichi Shirai; Yusuke Watanabe; Masanori Yamamoto; Kentaro Hayashida
Journal:  Eur Heart J Open       Date:  2021-11-15

2.  Changes in Antithrombotic Therapy Over Time and Durability of a Prasugrel WOEST-Like Regimen for Percutaneous Coronary Intervention Patients With Atrial Fibrillation - Post Hoc Analysis of the PENDULUM Mono and PENDULUM Registries.

Authors:  Koichi Nakao; Kazushige Kadota; Yoshihisa Nakagawa; Junya Shite; Hiroyoshi Yokoi; Ken Kozuma; Kengo Tanabe; Takashi Akasaka; Toshiro Shinke; Takafumi Ueno; Atsushi Hirayama; Shiro Uemura; Atsushi Harada; Takeshi Kuroda; Atsushi Takita; Raisuke Iijima; Yoshitaka Murakami; Shigeru Saito; Masato Nakamura
Journal:  Circ Rep       Date:  2022-04-21

3.  Validation of Japanese Bleeding Risk Criteria in Patients After Percutaneous Coronary Intervention and Comparison With Contemporary Bleeding Risk Criteria.

Authors:  Takeshi Shimizu; Yuya Sakuma; Yuta Kurosawa; Yuuki Muto; Akihiko Sato; Satoshi Abe; Tomofumi Misaka; Masayoshi Oikawa; Akiomi Yoshihisa; Takayoshi Yamaki; Kazuhiko Nakazato; Takafumi Ishida; Yasuchika Takeishi
Journal:  Circ Rep       Date:  2022-04-16

4.  Ischemic and Bleeding Outcomes According to the Academic Research Consortium High Bleeding Risk Criteria in All Comers Treated by Percutaneous Coronary Interventions.

Authors:  Daphné Doomun; Ianis Doomun; Sara Schukraft; Diego Arroyo; Selma Cook; Tibor Huwyler; Peter Wenaweser; Jean-Christophe Stauffer; Jean-Jacques Goy; Mario Togni; Serban Puricel; Stéphane Cook
Journal:  Front Cardiovasc Med       Date:  2021-12-02

5.  Prevalence of High Bleeding Risk among Hospitalized Suspected NSTEMI Patients.

Authors:  Henri Kesti; Henna Mäkinen; Kalle Mattila; Samuli Jaakkola; Mikko Lintu; Pekka Porela
Journal:  J Clin Med       Date:  2022-02-28       Impact factor: 4.241

6.  Practical Assessment of the Tradeoff between Fatal Bleeding and Coronary Thrombotic Risks using the Academic Research Consortium for High Bleeding Risk Criteria.

Authors:  Yohei Sotomi; Shungo Hikoso; Daisaku Nakatani; Tomoharu Dohi; Hiroya Mizuno; Katsuki Okada; Hirota Kida; Bolrathanak Oeun; Akihiro Sunaga; Taiki Sato; Tetsuhisa Kitamura; Yasuhiko Sakata; Hiroshi Sato; Masatsugu Hori; Issei Komuro; Yasushi Sakata
Journal:  J Atheroscler Thromb       Date:  2021-09-15       Impact factor: 4.394

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.